Skip to main content
Premium Trial:

Request an Annual Quote

Andrew Serafini, Pat Frain

Premium
Fenwick & West, a technology and life sciences law firm with offices in Seattle, Silicon Valley, San Francisco, and Boise, Idaho, said this week that Andrew Serafini has been named as a partner in its firm-wide intellectual property group.
 
Serafini is based in Fenwick & West’s Seattle office, where his practice focuses on IP counseling for life sciences companies, with particular expertise in the areas of immunology, molecular biology, molecular genetics, genomics, proteomics and protein chemistry, pharmaceuticals, and medical diagnostics.
 
Prior to joining Fenwick & West, Serafini was a partner at Woodcock Washburn in Seattle. He received a JD in 1998 from the University of California, Hastings College of Law. He also received a PhD in immunology in 1994 from Stanford University School of Medicine.
 

 
Pat Frain has been elected chair of ProTon Europe, a pan-European network of knowledge transfer offices, national knowledge transfer associations, and companies affiliated to universities and other public research organizations.
 
Frain is currently director of NovaUCD, the innovation and technology transfer center at University College Dublin.

The Scan

Nature Papers Examine Genomes of Centenarians, Transcription-Coupled DNA Repair

In Nature this week: analysis of centenarian genomes uncovers longevity-linked variants, and more.

Removal Inquiry

The Wall Street Journal reports that US lawmakers are seeking additional information about the request to remove SARS-CoV-2 sequence data from a database run by the National Institutes of Health.

Likely to End in Spring

Free lateral flow testing for SARS-CoV-2 may end in the UK by next spring, the head of Innova Medical Group says, according to the Financial Times.

Searching for More Codes

NPR reports that the US Department of Justice has accused an insurance and a data mining company of fraud.